Supply chain considerations for DMPA-SC introduction

Planning for and addressing supply chain challenges is part of achieving contraceptive security—ensuring clients can choose, access, and use family planning methods. This brief provides an overview of supply chain considerations for countries that are introducing or scaling up the injectable contraceptive subcutaneous DMPA (DMPA-SC) within the range of options available in their family planning programs.

For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.

Corporate author(s): PATH; John Snow, Inc.

Publication date: March 2020

Available materials

    1. Supply chain considerations for DMPA-SC introduction 306.4 KB PDF
    2. La chaîne d’approvisionnement : considérations pour l’introduction du DMPA-SC 314.2 KB PDF